Hematologic Malignancy
Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
CI-CAN-00006974Explore in graph →
Hematologic3 active trials
- NCIt
- C157624
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00006974Explore in graph →
Clinical trials
5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06735664 | Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation | recruiting | Phase 1 | 23 | City of Hope Medical CenterOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT03892044 | Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma | completed | Phase 1 | 7 | David Bond, MDOTHER | 1 | May 2, 2024 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 14 days agoSource updated Sep 16, 2026source: clinicaltrials